通过植物性饮食预防和逆转高血压诱导的冠状动脉微血管功能障碍
Rami S Najjar1,2, Nedumangalam Hekmatyar3, Yanling Wang1
1Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University Atlanta GA USA.
Journal of the American Heart Association
|November 12, 2025
概括
植物性饮食 (PBD) 可以预防和逆转冠状动脉微血管功能障碍 (CMD) 在高血压的老鼠. 这种饮食干预改善了内皮和血管光滑肌细胞功能,为人类心血管健康提供了希望.
科学领域:
- 心脏病学 心脏病学
- 营养科学 营养科学
- 血管生物学 血管生物学
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 是心血管不良结果的重要危险因素.
- 冠状动脉疾病源于内皮和血管光滑肌细胞 (VSMC) 功能受损.
- 高血压是CMD的一个关键因素.
研究的目的:
- 研究植物性饮食 (PBD) 在高血压大鼠模型中减轻CMD的潜力.
- 在高血压的背景下,评估PBD对内皮和VSMC功能的影响.
主要方法:
- 比较Wistar-Kyoto和自发高血压大鼠 (SHRs),从4周大开始食对照或PBD.
- 评估CMD使用心声回声学 (冠状动脉流量储备) 和心脏MRI.
- 评估内皮和VSMC功能,心脏氧化应激,炎症和纤维化.
- 通过16S测序和抗生素治疗探索肠道微生物群的作用.
主要成果:
- SHRs显示内皮细胞和VSMC功能障碍.
- 一个PBD没有降低血压,但有效地预防和逆转CMD.
- 消费PBD改善了内皮氧化合成酶功能和氧化介导的VSMC信号.
- 在SHR中,PBD摄入量减少了心脏氧化应激,炎症和纤维化.
结论:
- 一个PBD是有效的预防和逆转CMD在高血压的老鼠,独立于其对高血压的影响.
- 这些好处归因于改善了内皮和VSMC功能.
- 这些发现支持需要进行临床试验,评估人类CMD的PBD.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
578
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
578
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Hypertension II: Pathophysiology
765
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
765
Hypertension IV: Drug Therapy and Lifestyle Modifications
600
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
600
Hypertension and Regulation of Blood Pressure
3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863


